Nova Scotia Health Authority — Halifax, Nova Scotia

Public research footprint of Nova Scotia Health Authority, compiled from the ClinicalTrials.gov public registry.

173

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Myelodysplastic Syndrome · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT05564390 — MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… (Recruiting)
NCT03150693 — Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nova Scotia Health Authority?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.